ACPU
AMGN icon

Arrowgrass Capital Partners (US)’s Amgen AMGN Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-60,000
Closed -$11.7M – 333
2018
Q4 		$11.7M Buy
60,000
+59,400
+9,900% +$11.6M 0.43% 68
2018
Q3 		$12.4M Sell
600
-59,400
-99% -$11.7M 0.38% 76
2018
Q2 		$11.1M Buy
+60,000
New +$10.6M 0.38% 76
2018
Q1 		– Sell
-216,300
Closed -$37.6M – 153
2017
Q4 		$37.6M Buy
216,300
+213,304
+7,120% +$37.7M 0.36% 54
2017
Q3 		$55.9M Sell
2,996
-221
-7% -$39.2K 0.41% 61
2017
Q2 		$55.4M Buy
3,217
+664
+26% +$108K 0.42% 56
2017
Q1 		$41.9M Buy
2,553
+1,106
+76% +$184K 0.43% 53
2016
Q4 		$21.2M Buy
1,447
+612
+73% +$92.1K 0.24% 95
2016
Q3 		$13.9M Buy
835
+642
+333% +$109K 0.19% 111
2016
Q2 		$2.94M Sell
193
-257
-57% -$40K 0.03% 246
2016
Q1 		$6.75M Buy
450
+100
+29% +$14.9K 0.08% 154
2015
Q4 		$5.68M Buy
+350
New +$55K 0.07% 152

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s AMGN Position: Q3 2017 in Review

Arrowgrass Capital Partners (US) sold out of Amgen (AMGN) in Q3 2017, closing a stake of 10,904 shares — an estimated $1.93M sold.

Arrowgrass Capital Partners (US) first reported a position in AMGN in Q3 2013 and held it in 8 quarters. The position peaked at $30.8M in Q3 2014. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Arrowgrass Capital Partners (US) reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 10,904 Amgen shares in Q3 2017, an estimated $1.93M.
  • Arrowgrass Capital Partners (US) first reported a position in Amgen in Q3 2013 and held it in 8 quarters.
  • Arrowgrass Capital Partners (US)'s Amgen position peaked at $30.8M in Q3 2014.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2017, filed 14 Nov 2017.